Sign in
EYES Stock Price, Chart, Stats & News
Second Sight Medical Products, Inc.
Save
210.05M
Market cap
–
Current P/E
–
Forward P/E
EYES chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -67.55% |
ROE | -317.03% |
D/E | 1.20x |
Interest coverage ratio | – |
EYES valuation
P/E | – |
P/S | – |
P/B | 16.42x |
P/CF | -8.40x |
P/FCF | -6.53x |
P/OCF | -8.40x |
PEG | 0.13x |
EV multiple | -7.59x |
About
On August 30, 2022, Second Sight Medical Products, Inc. underwent a reverse merger, resulting in its acquisition by Nano Precision Medical, Inc. Previously, Second Sight specialized in the creation, production, and commercialization of implantable visual prosthetics, with the goal of restoring artificial vision to individuals who are blind. The company's overarching objective was to advance technologies designed to aid the sight-impaired community.
Similar securities
Based on sector and market capitalization
Report issue